Pacer Advisors Inc. Has $494,000 Stock Position in Universal Health Services, Inc. $UHS

Pacer Advisors Inc. trimmed its position in shares of Universal Health Services, Inc. (NYSE:UHS) by 52.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,762 shares of the health services provider’s stock after selling 3,035 shares during the period. Pacer Advisors Inc.’s holdings in Universal Health Services were worth $494,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in UHS. Elyxium Wealth LLC acquired a new stake in shares of Universal Health Services in the fourth quarter worth $25,000. CYBER HORNET ETFs LLC acquired a new position in Universal Health Services during the second quarter valued at $29,000. Larson Financial Group LLC lifted its stake in Universal Health Services by 302.9% in the 4th quarter. Larson Financial Group LLC now owns 141 shares of the health services provider’s stock worth $31,000 after acquiring an additional 106 shares in the last quarter. CENTRAL TRUST Co lifted its stake in Universal Health Services by 107.1% in the 1st quarter. CENTRAL TRUST Co now owns 174 shares of the health services provider’s stock worth $31,000 after acquiring an additional 90 shares in the last quarter. Finally, MUFG Securities EMEA plc acquired a new stake in Universal Health Services during the 2nd quarter worth about $31,000. 86.05% of the stock is owned by institutional investors and hedge funds.

Universal Health Services Stock Down 2.2%

UHS opened at $168.95 on Wednesday. The company has a market capitalization of $10.23 billion, a PE ratio of 6.88, a price-to-earnings-growth ratio of 0.94 and a beta of 1.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.12 and a quick ratio of 1.04. Universal Health Services, Inc. has a fifty-two week low of $140.08 and a fifty-two week high of $246.32. The business has a 50-day moving average of $153.54 and a 200-day moving average of $176.43.

Universal Health Services (NYSE:UHS) last announced its quarterly earnings results on Tuesday, July 28th. The health services provider reported $5.98 EPS for the quarter, beating the consensus estimate of $5.94 by $0.04. Universal Health Services had a return on equity of 19.39% and a net margin of 8.42%.The business had revenue of $4.64 billion during the quarter, compared to analysts’ expectations of $4.58 billion. During the same quarter in the previous year, the business posted $5.35 EPS. The firm’s quarterly revenue was up 8.3% compared to the same quarter last year. Equities research analysts forecast that Universal Health Services, Inc. will post 23.16 EPS for the current fiscal year.

Universal Health Services Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Tuesday, September 1st. Universal Health Services’s payout ratio is currently 3.26%.

Key Headlines Impacting Universal Health Services

Here are the key news stories impacting Universal Health Services this week:

• Positive Sentiment: Zacks Research raised its fiscal 2026 earnings estimate slightly to $23.07 per share from $23.04. However, the new forecast remains just below the broader consensus estimate of $23.15.
• Negative Sentiment: Zacks reduced its Q3 2026 EPS forecast to $5.48 from $5.63 and its Q4 2026 estimate to $5.99 from $6.30. The combined revisions point to weaker-than-previously-expected near-term earnings momentum.
• Negative Sentiment: Forward estimates were also trimmed for Q1 2027 EPS to $5.77 from $5.93, Q3 2027 EPS to $6.10 from $6.21, and Q4 2027 EPS to $6.42 from $6.53. Zacks lowered its full-year 2027 forecast to $24.25 from $24.59.
• Negative Sentiment: Longer-term expectations weakened as well: Q1 2028 EPS was cut to $6.27 from $6.35, Q2 2028 EPS to $6.56 from $6.57, and fiscal 2028 EPS to $26.47 from $27.10. The broad pattern of estimate reductions is the primary negative catalyst for UHS today.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on UHS shares. Mizuho dropped their target price on Universal Health Services from $267.00 to $230.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. Wall Street Zen cut shares of Universal Health Services from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. The Goldman Sachs Group lowered their price objective on shares of Universal Health Services from $242.00 to $190.00 and set a “neutral” rating on the stock in a research report on Thursday, July 30th. TD Cowen dropped their price objective on shares of Universal Health Services from $230.00 to $197.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of Universal Health Services from $261.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Five equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $204.93.

About Universal Health Services

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.